Logo image of ALB

ALBEMARLE CORP (ALB) Stock Fundamental Analysis

NYSE:ALB - New York Stock Exchange, Inc. - US0126531013 - Common Stock - Currency: USD

61.86  +0.29 (+0.47%)

After market: 62.8405 +0.98 (+1.59%)

Fundamental Rating

3

ALB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. ALB may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ALB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALB has reported negative net income.
In the past year ALB had a positive cash flow from operations.
Of the past 5 years ALB 4 years were profitable.
In the past 5 years ALB always reported a positive cash flow from operatings.
ALB Yearly Net Income VS EBIT VS OCF VS FCFALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

With a Return On Assets value of -7.69%, ALB is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -13.04%, ALB is doing worse than 75.29% of the companies in the same industry.
Industry RankSector Rank
ROA -7.69%
ROE -13.04%
ROIC N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ALB Yearly ROA, ROE, ROICALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

ALB's Gross Margin of 3.53% is on the low side compared to the rest of the industry. ALB is outperformed by 87.06% of its industry peers.
In the last couple of years the Gross Margin of ALB has declined.
ALB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
ALB Yearly Profit, Operating, Gross MarginsALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

3

2. Health

2.1 Basic Checks

ALB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALB remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALB has more shares outstanding
ALB has a better debt/assets ratio than last year.
ALB Yearly Shares OutstandingALB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALB Yearly Total Debt VS Total AssetsALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.43, we must say that ALB is in the distress zone and has some risk of bankruptcy.
ALB has a Altman-Z score of 1.43. This is in the lower half of the industry: ALB underperforms 67.06% of its industry peers.
ALB has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
ALB has a Debt to Equity ratio of 0.31. This is in the better half of the industry: ALB outperforms 72.94% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 1.43
ROIC/WACCN/A
WACC8.11%
ALB Yearly LT Debt VS Equity VS FCFALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 2.11 indicates that ALB has no problem at all paying its short term obligations.
The Current ratio of ALB (2.11) is comparable to the rest of the industry.
A Quick Ratio of 1.26 indicates that ALB should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.26, ALB is in line with its industry, outperforming 56.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.26
ALB Yearly Current Assets VS Current LiabilitesALB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

ALB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -122.82%.
ALB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -39.34%.
Measured over the past years, ALB shows a quite strong growth in Revenue. The Revenue has been growing by 8.42% on average per year.
EPS 1Y (TTM)-122.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.23%
Revenue 1Y (TTM)-39.34%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-20.86%

3.2 Future

Based on estimates for the next years, ALB will show a very strong growth in Earnings Per Share. The EPS will grow by 65.34% on average per year.
Based on estimates for the next years, ALB will show a quite strong growth in Revenue. The Revenue will grow by 13.72% on average per year.
EPS Next Y42.64%
EPS Next 2Y64.88%
EPS Next 3Y56.41%
EPS Next 5Y65.34%
Revenue Next Year-10.9%
Revenue Next 2Y-0.66%
Revenue Next 3Y5.17%
Revenue Next 5Y13.72%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALB Yearly Revenue VS EstimatesALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B 8B 10B
ALB Yearly EPS VS EstimatesALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALB. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 36.80, ALB can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ALB is valued a bit more expensive than 71.76% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.99. ALB is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 36.8
ALB Price Earnings VS Forward Price EarningsALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

80.00% of the companies in the same industry are cheaper than ALB, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 59.8
ALB Per share dataALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALB's earnings are expected to grow with 56.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.88%
EPS Next 3Y56.41%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.82%, ALB has a reasonable but not impressive dividend return.
The stock price of ALB dropped by -23.83% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.79, ALB pays a bit more dividend than its industry peers.
ALB's Dividend Yield is comparable with the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 2.82%

5.2 History

On average, the dividend of ALB grows each year by 13.04%, which is quite nice.
ALB has paid a dividend for at least 10 years, which is a reliable track record.
ALB has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.04%
Div Incr Years30
Div Non Decr Years30
ALB Yearly Dividends per shareALB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ALB has negative earnings and hence a negative payout ratio. The dividend may be in danger.
ALB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-27.05%
EPS Next 2Y64.88%
EPS Next 3Y56.41%
ALB Yearly Income VS Free CF VS DividendALB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

ALBEMARLE CORP

NYSE:ALB (5/13/2025, 8:16:03 PM)

After market: 62.8405 +0.98 (+1.59%)

61.86

+0.29 (+0.47%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners99.62%
Inst Owner Change-3.7%
Ins Owners0.22%
Ins Owner Change14.75%
Market Cap7.28B
Analysts69.09
Price Target83.98 (35.76%)
Short Float %14.56%
Short Ratio5.03
Dividend
Industry RankSector Rank
Dividend Yield 2.82%
Yearly Dividend2.65
Dividend Growth(5Y)13.04%
DP-27.05%
Div Incr Years30
Div Non Decr Years30
Ex-Date03-14 2025-03-14 (0.405)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.02%
Min EPS beat(2)-54.53%
Max EPS beat(2)68.57%
EPS beat(4)1
Avg EPS beat(4)-81.38%
Min EPS beat(4)-249.28%
Max EPS beat(4)68.57%
EPS beat(8)3
Avg EPS beat(8)-26.95%
EPS beat(12)7
Avg EPS beat(12)-13%
EPS beat(16)11
Avg EPS beat(16)-4.4%
Revenue beat(2)0
Avg Revenue beat(2)-8.29%
Min Revenue beat(2)-8.69%
Max Revenue beat(2)-7.88%
Revenue beat(4)1
Avg Revenue beat(4)-3.24%
Min Revenue beat(4)-8.69%
Max Revenue beat(4)5.88%
Revenue beat(8)3
Avg Revenue beat(8)-1.95%
Revenue beat(12)3
Avg Revenue beat(12)-2.81%
Revenue beat(16)5
Avg Revenue beat(16)-1.38%
PT rev (1m)-15.31%
PT rev (3m)-25.67%
EPS NQ rev (1m)-98.48%
EPS NQ rev (3m)-456.01%
EPS NY rev (1m)-89.81%
EPS NY rev (3m)-400.15%
Revenue NQ rev (1m)-0.95%
Revenue NQ rev (3m)-9.76%
Revenue NY rev (1m)-3.56%
Revenue NY rev (3m)-9.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 36.8
P/S 1.43
P/FCF N/A
P/OCF 6.33
P/B 0.73
P/tB 0.89
EV/EBITDA 59.8
EPS(TTM)-2.78
EYN/A
EPS(NY)1.68
Fwd EY2.72%
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)9.77
OCFY15.79%
SpS43.3
BVpS85.24
TBVpS69.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.69%
ROE -13.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.53%
FCFM N/A
ROA(3y)6.03%
ROA(5y)4.56%
ROE(3y)12.4%
ROE(5y)9.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-66.02%
GM growth 5Y-49.18%
F-Score4
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA 20.2
Cap/Depr 205.72%
Cap/Sales 25.31%
Interest Coverage N/A
Cash Conversion 742.04%
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 1.26
Altman-Z 1.43
F-Score4
WACC8.11%
ROIC/WACCN/A
Cap/Depr(3y)401.9%
Cap/Depr(5y)389.55%
Cap/Sales(3y)23.64%
Cap/Sales(5y)25.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-122.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-169.23%
EPS Next Y42.64%
EPS Next 2Y64.88%
EPS Next 3Y56.41%
EPS Next 5Y65.34%
Revenue 1Y (TTM)-39.34%
Revenue growth 3Y17.35%
Revenue growth 5Y8.42%
Sales Q2Q%-20.86%
Revenue Next Year-10.9%
Revenue Next 2Y-0.66%
Revenue Next 3Y5.17%
Revenue Next 5Y13.72%
EBIT growth 1Y40.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year160.58%
EBIT Next 3Y46.65%
EBIT Next 5Y39.51%
FCF growth 1Y-114.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-52.55%
OCF growth 3Y26.81%
OCF growth 5Y-0.49%